Annual Interest Expense
$11.41 M
-$157.00 K-1.36%
31 December 2023
Summary:
Galera Therapeutics annual interest expense is currently $11.41 million, with the most recent change of -$157.00 thousand (-1.36%) on 31 December 2023. During the last 3 years, it has risen by +$6.53 million (+133.89%). GRTX annual interest expense is now -1.36% below its all-time high of $11.57 million, reached on 31 December 2022.GRTX Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Interest Expense
$0.00
$0.000.00%
30 June 2024
Summary:
Galera Therapeutics quarterly interest expense is currently $0.00, unchanged on 30 June 2024. Over the past year, it has dropped by -$2.09 million (-100.00%). GRTX quarterly interest expense is now -100.00% below its all-time high of $4.40 million, reached on 30 June 2023.GRTX Quarterly Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Interest Expense
$2.79 M
-$4.40 M-61.17%
30 June 2024
Summary:
Galera Therapeutics TTM interest expense is currently $2.79 million, with the most recent change of -$4.40 million (-61.17%) on 30 June 2024. Over the past year, it has dropped by -$11.24 million (-80.10%). GRTX TTM interest expense is now -81.62% below its all-time high of $15.19 million, reached on 30 June 2023.GRTX TTM Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
GRTX Interest Expense Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -1.4% | -100.0% | -80.1% |
3 y3 years | +133.9% | -100.0% | -54.5% |
5 y5 years | +5088.2% | -100.0% | +20.7% |
GRTX Interest Expense High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3 years | -1.4% | +133.9% | -100.0% | -81.6% | at low | |
5 y | 5 years | -1.4% | +5088.2% | -100.0% | -81.6% | +20.7% | |
alltime | all time | -1.4% | -100.0% | -81.6% |
Galera Therapeutics Interest Expense History
Date | Annual | Quarterly | TTM |
---|---|---|---|
June 2024 | - | $0.00(0.0%) | $2.79 M(-61.2%) |
Mar 2024 | - | $0.00(-100.0%) | $7.19 M(-37.0%) |
Dec 2023 | $11.41 M(-1.4%) | $705.00 K(-66.2%) | $11.41 M(-18.7%) |
Sept 2023 | - | $2.09 M(-52.6%) | $14.03 M(-7.6%) |
June 2023 | - | $4.40 M(+4.2%) | $15.19 M(+12.6%) |
Mar 2023 | - | $4.22 M(+27.0%) | $13.49 M(+16.6%) |
Dec 2022 | $11.57 M(+60.8%) | $3.32 M(+2.4%) | $11.57 M(+9.6%) |
Sept 2022 | - | $3.25 M(+20.2%) | $10.56 M(+9.5%) |
June 2022 | - | $2.70 M(+17.2%) | $9.64 M(+16.9%) |
Mar 2022 | - | $2.30 M(-0.4%) | $8.24 M(+14.6%) |
Dec 2021 | $7.19 M | $2.31 M(-0.6%) | $7.19 M(+17.2%) |
Sept 2021 | - | $2.33 M(+78.7%) | $6.14 M(+21.6%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
June 2021 | - | $1.30 M(+3.9%) | $5.04 M(+0.1%) |
Mar 2021 | - | $1.25 M(-0.2%) | $5.04 M(+3.2%) |
Dec 2020 | $4.88 M(+61.0%) | $1.25 M(+1.6%) | $4.88 M(+7.0%) |
Sept 2020 | - | $1.24 M(-4.6%) | $4.56 M(+7.5%) |
June 2020 | - | $1.29 M(+18.3%) | $4.25 M(+15.2%) |
Mar 2020 | - | $1.09 M(+16.9%) | $3.69 M(+21.7%) |
Dec 2019 | $3.03 M(+1277.7%) | $937.00 K(+2.1%) | $3.03 M(+31.0%) |
Sept 2019 | - | $918.00 K(+24.7%) | $2.31 M(+65.8%) |
June 2019 | - | $736.00 K(+67.7%) | $1.40 M(+111.7%) |
Mar 2019 | - | $439.00 K(+99.5%) | $659.00 K(+199.5%) |
Dec 2018 | $220.00 K(>+9900.0%) | $220.00 K(>+9900.0%) | $220.00 K(>+9900.0%) |
Sept 2018 | - | $0.00 | $0.00 |
Dec 2017 | $0.00 | - | - |
FAQ
- What is Galera Therapeutics annual interest expense?
- What is the all time high annual interest expense for Galera Therapeutics?
- What is Galera Therapeutics annual interest expense year-on-year change?
- What is Galera Therapeutics quarterly interest expense?
- What is the all time high quarterly interest expense for Galera Therapeutics?
- What is Galera Therapeutics quarterly interest expense year-on-year change?
- What is Galera Therapeutics TTM interest expense?
- What is the all time high TTM interest expense for Galera Therapeutics?
- What is Galera Therapeutics TTM interest expense year-on-year change?
What is Galera Therapeutics annual interest expense?
The current annual interest expense of GRTX is $11.41 M
What is the all time high annual interest expense for Galera Therapeutics?
Galera Therapeutics all-time high annual interest expense is $11.57 M
What is Galera Therapeutics annual interest expense year-on-year change?
Over the past year, GRTX annual interest expense has changed by -$157.00 K (-1.36%)
What is Galera Therapeutics quarterly interest expense?
The current quarterly interest expense of GRTX is $0.00
What is the all time high quarterly interest expense for Galera Therapeutics?
Galera Therapeutics all-time high quarterly interest expense is $4.40 M
What is Galera Therapeutics quarterly interest expense year-on-year change?
Over the past year, GRTX quarterly interest expense has changed by -$2.09 M (-100.00%)
What is Galera Therapeutics TTM interest expense?
The current TTM interest expense of GRTX is $2.79 M
What is the all time high TTM interest expense for Galera Therapeutics?
Galera Therapeutics all-time high TTM interest expense is $15.19 M
What is Galera Therapeutics TTM interest expense year-on-year change?
Over the past year, GRTX TTM interest expense has changed by -$11.24 M (-80.10%)